BSc (Hons), PhD
Head of Molecular Neurotrauma and Haemostasis Group, National Trauma Research Institute
Head, Basic Research, Trauma Bleeding Group, The Alfred
NHMRC Principal Research Fellow and Director of the Molecular Neurotrauma and Haemostasis Group, Monash University
Professor Robert Medcalf is the Head of the Basic Research Program at The Alfred hospital. His research activities focus on the host response to traumatic brain injury and ischaemic stroke. He has a particular interest in the role of the fibrinolytic and haemostatic systems at modulating brain function in neuropathological conditions.
Professor Medcalf obtained his Ph.D. in 1984 at the University of Melbourne. He undertook an extended post-doctoral training position at the University of Lausanne, Switzerland, before returning to Melbourne as an RD Wright Fellow in 1993. Professor Medcalf has obtained continuous NHMRC support for his research programs since 1993 and was appointed into the NHMRC Fellowship scheme in 2003. Professor Medcalf served two terms as Chairman of the International Society on Fibrinolysis and Proteolysis (ISFP) and has been a member of the ISFP Council Executive since 2002. Professor Medcalf is currently Chairman of the Brain Foundation (Victoria).
Professor Medcalf is exploring the contribution of the fibrinolytic and haemostatic systems in the host response to traumatic brain injury (TBI). His laboratory has shown that the fibrinolytic system directly contributes to injury severity in TBI by increasing blood brain barrier permeability and has identified novel compounds that can attenuate this process. He is also actively engaged in the PATCH trial being undertaken at NTRI that is evaluating the effectiveness of anti-fibrinolytic agents in patients with severe trauma. Professor Medcalf has been awarded the International ISFP Prize for 2016 which is awarded bi-annually for outstanding contributions to the field of fibrinolysis, thrombolysis and proteolysis (for information: www.fibrinolysis.org).